Thrombosis in the Neonatal Intensive Care Unit

Area of Science:

• Neonatal Medicine
• Pediatric Hematology
• Thrombosis Research

Background:

• Neonates, especially critically ill and premature infants, are at high risk for thromboembolic complications, particularly venous thromboembolism (VTE).
• The incidence of VTE in neonates has notably increased in recent decades.
• Multiple risk factors contribute to this heightened risk, including immature hemostasis, infection susceptibility, and frequent central venous catheter use.

Purpose of the Study:

• To review the current understanding of thromboembolic complications in neonates.
• To discuss the challenges in diagnosis and management due to limited neonatal-specific data.
• To highlight the need for further research into optimal treatment strategies.

Main Methods:

• Review of existing literature and current guidelines on neonatal thromboembolism.
• Analysis of risk factors, clinical presentations, and diagnostic approaches.
• Evaluation of current treatment recommendations and their limitations.

Main Results:

• Neonates exhibit a high incidence of VTE, influenced by factors like prematurity and critical illness.
• Clinical presentation and management vary significantly based on etiology, site, and comorbidities.
• Existing guidelines are largely based on consensus and adult data extrapolation, lacking robust neonatal evidence.

Conclusions:

• Optimal management strategies for neonatal thromboembolic complications require further investigation.
• High-quality research is crucial to develop evidence-based guidelines for this vulnerable population.
• Anticoagulation is recommended in specific neonatal VTE scenarios, but optimal approaches need clarification.